Visit https://www.peervoice.com/SCQ860 to view the entire programme with slides. After completing “Therapeutic Sequencing in Patients With Advanced or High Risk Hodgkin Lymphoma: Strategies in Action”, participants will be able to: Identify patient- and disease-related characteristics that might affect treatment selection for patients with Hodgkin lymphoma; Describe the rationale for evolving treatment strategies in patients with Hodgkin lymphoma; Assess the evidence for emerging treatment strategies for Hodgkin lymphoma.